US Drug Recall Register
Class I · High risk Completed Initiated Apr 5, 2022 (4 years ago)

Humalog KwikPen

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

What was recalled

Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

Recalling firm
Cardinal Health Inc.
NDC code
0002-8799-59
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0882-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Insulin recalls

See all
Class II · Moderate risk Completed

Sterile Diluent

Reason CGMP Deviations

Eli Lilly & Company D-0445-2024
Class II · Moderate risk Ongoing

Admelog

Reason Lack of Assurance of Sterility: Malformed crimped collar seal

Sanofi-Aventis U.S. LLC NDC 0024-5926-05 D-0575-2023
Class I · High risk Terminated

Insulin Glargine

Reason Labeling: Missing label: Label missing from some prefilled pens.

Mylan Pharmaceuticals Inc NDC 49502-394-71 D-1292-2022
Class I · High risk Terminated

Insulin Glargine

Reason Labeling: Missing label on the vial

Mylan Pharmaceuticals Inc NDC 49502-393-80 D-0845-2022
Class I · High risk Terminated

Semglee

Reason Labeling: Missing Label: label missing from some Semglee prefilled pens.

Mylan Pharmaceuticals Inc NDC 49502-0196-71 D-0462-2022